Stay updated on Modakafusp Alfa in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Modakafusp Alfa in Multiple Myeloma Clinical Trial page.

Latest updates to the Modakafusp Alfa in Multiple Myeloma Clinical Trial page
- Check6 days agoChange DetectedThe page now shows Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.0%

- Check14 days agoChange DetectedThe sponsor is now listed as Teva Branded Pharmaceutical Products R&D LLC/Inc, replacing Takeda. New IPD sharing details outline data access, de-identification, and the contact for requests.SummaryDifference0.7%

- Check21 days agoChange DetectedThe page now includes a glossary toggle and related topics (e.g., MedlinePlus Genetics); several metadata fields and versioning information were updated or added (Results First Posted, Last Update Submitted/Posted, No FEAR Act Data, Revision v3.4.0) and older metadata entries were removed.SummaryDifference0.2%

- Check28 days agoChange DetectedPage revision updated to v3.3.4. The 'Multiple myeloma' topic and the 'MedlinePlus Genetics' related topics were removed.SummaryDifference0.1%

- Check42 days agoChange DetectedAdded a related topics section for MedlinePlus Genetics featuring 'Multiple Myeloma' on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page no longer displays the disease label 'Multiple Myeloma' or the related topic 'MedlinePlus Genetics'. As a result, key context and links that help users understand the study focus and access background information are missing.SummaryDifference0.1%

Stay in the know with updates to Modakafusp Alfa in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Modakafusp Alfa in Multiple Myeloma Clinical Trial page.